Small cap
SMS Pharmaceuticals books ₹87.61 cr annual profit
Annual results confirm steady growth with a final dividend of ₹0.40 per share.
SMS Pharmaceuticals hits ₹87.61 cr profit as FY26 growth hits target
Revenue climbed 13% to ₹886.87 cr, matching earlier guidance. The board approved a dividend of ₹0.40 per share.
Symphony writes off its ₹348 cr Australian investment
A failed overseas expansion and a weak summer combine to force a ₹141 crore loss. Management has officially pulled the plug on the Australian unit.
Vaibhav Global pares growth targets as US, UK retail headwinds persist
Retailer lowers medium-term revenue growth guidance to 10-12% from mid-teens as US sales growth stalls at 1% for a third year.
Prakash Industries FY26 sales drop 13% as audit qualification persists
Annual profit fell to ₹333 cr. The auditor continues to dispute deferred tax accounting.
Century Enka lifts margin guidance as tyre-cord project slips to FY27
Management moves margin targets to 7-10% on energy savings, while the long-delayed polyester tyre cord unit hits another snag.
Prakash Industries FY26 profit dips to ₹333 cr
The steel and mining firm beat last year's dividend with a payout of ₹1.80 per share, even as annual profits retreated.
Dhanuka Agritech transcript adds no new information to FY27 guidance
A routine record of the May 19 earnings call confirms previously disclosed targets for growth and biostimulant contributions.
Sanghvi Movers targets FY27 growth matching last year's 37% jump
With a ₹1,053 cr order book and Saudi operations nearing break-even, the company plans ₹590 cr of new capex for FY27.
GPT Healthcare earnings drag as new Raipur facility losses bite
Revenue grew 15% to ₹478.5 crore, but profits slumped as the company absorbed startup costs at its newest hospital.
Electronics Mart's profit falls a third on fire, store sale
Revenue rose 6.7%, but exceptional charges slashed net profit by 33%. A strong Q4 couldn't offset the full-year hit.
Prabha Energy posts ₹47.32 lakh FY26 profit after a year of losses
The small-cap explorer swung to profit on higher revenue and a subsidiary sale, but the absolute numbers are tiny against a ₹2,468 crore market cap.
SMS Pharmaceuticals grows FY26 revenue to ₹886.87 cr
The company’s annual results reflect steady growth alongside a final dividend of ₹0.40 per share.
Panorama Studios sets date for FY26 audit review
A routine regulatory filing confirms the upcoming board meeting to finalize annual results.
Mobikwik is carving out its ₹261 cr lending business
The company is moving its lending services to a subsidiary as a regulatory requirement to secure its own NBFC license.
Windlas Biotech misses Plant 6 timeline as regulatory hit cuts revenue
Regulatory action wiped out the company's codeine syrup business, while geopolitical tension and solvent costs weigh on margins.
SMS Pharma posts 28% profit jump for FY26; dividend is a token ₹0.40
Full-year net profit grew to ₹87.61 crore on 13.3% revenue growth. The market has seen the quarterly build-up already.
Ganesha Ecosphere scraps ₹500 cr Odisha project, trims margin outlook
Management is pivoting toward a smaller, brownfield expansion in Warangal while resetting FY27 consolidated EBITDA expectations to ₹225-250 cr.
Goodluck India wins its largest-ever export order in Nepal
The company landed a $13.6M contract to supply 14,500 MT of transmission towers, a win representing 2.4% of its market cap.
S.P. Apparels targets ₹2,000 cr revenue despite shifting guidance
Management clarified that EBITDA margin targets apply solely to its garmenting business, while delays hit the Salem expansion.
Suraksha Diagnostic cools growth targets to 15% for FY27
Management pivots on performance metrics while shifting toward public-private partnerships, drawing scrutiny.
Flair cuts pen growth guidance to 5%, flags Q1 margin hit from crude costs
Management downgraded its core pen-segment outlook and raised capex to ₹80-90 cr. A 4% EBITDA margin headwind in Q1 is the first sign of the trade-off.
Ashoka Buildcon guides for 20% revenue growth in FY27
The infrastructure firm targets ₹8,000-10,000 crore in new orders and plans to cut standalone debt by more than half through asset sales.
GRP's EBITDA margin fell to 7% as tariffs crushed exports
Quarterly profit collapsed from 21% to 7% of revenue. A key growth project is delayed again, and the polymer composite business is shut.
VRL cuts FY27 tonnage guidance to 6-7% after strong profit year
The logistics firm just posted 29% profit growth. Management now says the next twelve months will be slower.